• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

4.350 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125
Open 4.350
Bid (Size) 4.210 (200)
Ask (Size) 6.860 (100)
Prev. Close 4.350
Today's Range 4.350 - 4.350
52wk Range 3.760 - 8.590
Shares Outstanding 93,500,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Cash-Burning Stock to Target This Week and 2 We Question
Today 0:34 EDT
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them... 
Via StockStory
News headline image
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
April 09, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire

Performance

YTD
-29.2%
-29.2%
1 Month
-6.7%
-6.7%
3 Month
-33.8%
-33.8%
6 Month
-44.5%
-44.5%
1 Year
-46.2%
-46.2%

More News

Read More
News headline image
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
April 05, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks with Open Questions
April 02, 2026
Via StockStory
Myriad Genetics Inc (NASDAQ:MYGN) Stock Surges 19.6% on Strong Q4 Earnings Beat ↗
February 23, 2026
Via Chartmill
News headline image
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
March 27, 2026
Via StockStory
Topics Government Stocks
News headline image
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
March 17, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off
March 17, 2026
Via StockStory
News headline image
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
March 11, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Sell MYGN and 1 Stock to Buy Instead
March 11, 2026
Via StockStory
News headline image
Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know
March 10, 2026
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
3 Stocks Under $10 We Keep Off Our Radar
March 10, 2026
Via StockStory
News headline image
2 Unprofitable Stocks on Our Buy List and 1 We Brush Off
March 05, 2026
Via StockStory
News headline image
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
March 03, 2026
Via StockStory
Topics Earnings Economy Stocks
News headline image
Myriad Commercially Launches Precise MRD with Select Community Oncologists
March 02, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
February 27, 2026
Via StockStory
Topics Economy Government Stocks
News headline image
Why Myriad Genetics (MYGN) Stock Is Trading Up Today
February 24, 2026
Via StockStory
Topics Government World Trade
News headline image
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
February 24, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics (MYGN) Q4 2025 Earnings Transcript ↗
February 23, 2026
Via The Motley Fool
What's going on in today's after hours session ↗
February 23, 2026
Via Chartmill
News headline image
Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%
February 23, 2026
Via StockStory
News headline image
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
February 23, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
February 23, 2026
Via StockStory
Topics Government World Trade
News headline image
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
February 19, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
February 16, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.350
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 04/10/26 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 406.72M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 407M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap